CD19 and acute lymphoblastic leukemia: Moreover, CaSpER and Ballele frequency (BAF) analysis showed that the potential pre-existing CD19neg B-ALL cells harbored genomic deletions in the same chromosome location as the other B-ALL cells, further confirming the presence of true B-ALL cells that did not express CD19 before CAR T-cell treatment [101].